---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-000221"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T03:00:23.377919+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Lunai Bioworks receives Nasdaq delisting notice; appeals hearing requested

## Summary
- Notice received Feb 6, 2026: bid price closed below $1.00 for 30 consecutive business days through Feb 5, 2026.
- Ineligible for 180-day compliance period due to 1-for-10 reverse stock split on Sep 30, 2025 (Nasdaq Rule 5810(c)(3)(A)(iv)).
- Suspension and Form 25 filing scheduled for Feb 18, 2026 unless hearing request stays action.
- Company timely requested hearing before Nasdaq Hearings Panel by Feb 13, 2026; outcome uncertain.
- Delisting would deregister securities under Section 12(b) of Exchange Act.

## SEC filing metadata
- accession: 0001731122-26-000221
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112226000221/0001731122-26-000221-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112226000221/e7323_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-000221
- JSON: https://secwatch.observer/filing/0001731122-26-000221.json
- Plain text: https://secwatch.observer/filing/0001731122-26-000221.txt

## Source-grounded claims
- claim_id: 82aebf21bee25232335edd5823cd539e3ce59786
  claim: Lunai Bioworks Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).
  evidence_excerpt: February 6, 2026, Lunai Bioworks, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq staff has determined to delist the Company’s securities from The Nasdaq Capital Market. The Notice states that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, as the bid price of the Company’s securities closed below $1.00 per share for 30 consecutive business days from December 23, 2025 through February 5
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112226000221/0001731122-26-000221-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.